Answers are grounded in this paper and cite their sources.
Demonstrates a conversational agent's effectiveness for reducing depressive and anxious symptoms, suggesting future clinical applications.
Our study presents a conversational agent with multiple functionalities and shows that GPT-4o outperforms Llama 3.1-8B in performance, although at a higher cost. This platform could be used in future clinical trials or real-world implementation studies.
No takes yet. Share an insight, caveat, or question.
Villarreal-Zegarra et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: